INTERCEPT PHARMACEUTICALS, INC.·4

Oct 3, 7:01 PM ET

Kim Richard J 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Oct 3, 2019

Insider Transaction Report

Form 4
Period: 2019-10-01
Kim Richard J
SVP, Commercial US
Transactions
  • Tax Payment

    Common Stock

    2019-10-01$65.87/sh267$17,58716,747 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person.

Documents

1 file
  • 4
    tv530560_4.xmlPrimary

    OWNERSHIP DOCUMENT